TY - JOUR
T1 - Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer
AU - Suraweera, Nirosha
AU - Mouradov, Dmitri
AU - Li, Shan
AU - Jorissen, Robert N.
AU - Hampson, Debbie
AU - Ghosh, Anil
AU - Sengupta, Neel
AU - Thaha, Mohamed
AU - Ahmed, Shafi
AU - Kirwan, Michael
AU - Aleva, Floor
AU - Propper, David
AU - Feakins, Roger M.
AU - Vulliamy, Tom
AU - Elwood, Ngaire J.
AU - Tian, Pei
AU - Ward, Robyn L.
AU - Hawkins, Nicholas J.
AU - Xu, Zheng Zhou
AU - Molloy, Peter L.
AU - Jones, Ian T.
AU - Croxford, Matthew
AU - Gibbs, Peter
AU - Silver, Andrew
AU - Sieber, Oliver M.
PY - 2016/4/26
Y1 - 2016/4/26
N2 - Telomeric dysfunction is linked to colorectal cancer (CRC) initiation. However, the relationship of normal tissue and tumor telomere lengths with CRC progression, molecular features and prognosis is unclear. Here, we measured relative telomere length (RTL) by real-time quantitative PCR in 90 adenomas (aRTL), 419 stage I-IV CRCs (cRTL) and adjacent normal mucosa (nRTL). Age-adjusted RTL was analyzed against germline variants in telomere biology genes, chromosome instability (CIN), microsatellite instability (MSI), CpG island methylator phenotype (CIMP), TP53, KRAS, BRAF mutations and clinical outcomes. In 509 adenoma or CRC patients, nRTL decreased with advancing age. Female gender, proximal location and the TERT rs2736100 G allele were independently associated with longer age-adjusted nRTL. Adenomas and carcinomas exhibited telomere shortening in 79% and 67% and lengthening in 7% and 15% of cases. Age-adjusted nRTL and cRTL were independently associated with tumor stage, decreasing from adenoma to stage III and leveling out or increasing from stage III to IV, respectively. Cancer MSI, CIMP, TP53, KRAS and BRAF status were not related to nRTL or cRTL. Near-tetraploid CRCs exhibited significantly longer cRTLs than CIN- and aneuploidy CRCs, while cRTL was significantly shorter in CRCs with larger numbers of chromosome breaks. Age-adjusted nRTL, cRTL or cRTL:nRTL ratios were not associated with disease-free or overall survival in stage II/III CRC. Taken together, our data show that both normal mucosa and tumor RTL are independently associated with CRC progression, and highlight divergent associations of CRC telomere length with tumor CIN profiles.
AB - Telomeric dysfunction is linked to colorectal cancer (CRC) initiation. However, the relationship of normal tissue and tumor telomere lengths with CRC progression, molecular features and prognosis is unclear. Here, we measured relative telomere length (RTL) by real-time quantitative PCR in 90 adenomas (aRTL), 419 stage I-IV CRCs (cRTL) and adjacent normal mucosa (nRTL). Age-adjusted RTL was analyzed against germline variants in telomere biology genes, chromosome instability (CIN), microsatellite instability (MSI), CpG island methylator phenotype (CIMP), TP53, KRAS, BRAF mutations and clinical outcomes. In 509 adenoma or CRC patients, nRTL decreased with advancing age. Female gender, proximal location and the TERT rs2736100 G allele were independently associated with longer age-adjusted nRTL. Adenomas and carcinomas exhibited telomere shortening in 79% and 67% and lengthening in 7% and 15% of cases. Age-adjusted nRTL and cRTL were independently associated with tumor stage, decreasing from adenoma to stage III and leveling out or increasing from stage III to IV, respectively. Cancer MSI, CIMP, TP53, KRAS and BRAF status were not related to nRTL or cRTL. Near-tetraploid CRCs exhibited significantly longer cRTLs than CIN- and aneuploidy CRCs, while cRTL was significantly shorter in CRCs with larger numbers of chromosome breaks. Age-adjusted nRTL, cRTL or cRTL:nRTL ratios were not associated with disease-free or overall survival in stage II/III CRC. Taken together, our data show that both normal mucosa and tumor RTL are independently associated with CRC progression, and highlight divergent associations of CRC telomere length with tumor CIN profiles.
KW - Chromosome instability
KW - Colorectal cancer
KW - Prognosis
KW - Telomere length
UR - http://www.scopus.com/inward/record.url?scp=84978049889&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.9015
DO - 10.18632/oncotarget.9015
M3 - Article
AN - SCOPUS:84978049889
SN - 1949-2553
VL - 7
SP - 36474
EP - 36488
JO - Oncotarget
JF - Oncotarget
IS - 24
ER -